Clinical Trial Update: Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy with or without binimetinib for advanced biliary tract cancers. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Distal Bile Duct Cancer
• Extrahepatic Cholangiocarcinoma
• Gallbladder Cancer
• Hilar Cholangiocarcinoma
• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Binimetinib (binimetinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING